Jeremy Goldhaber-Fiebert

Jeremy Goldhaber-Fiebert, PhD, is a Professor of Health Policy, a Core Faculty Member at the Center for Health Policy and the Department of Health Policy, and a Faculty Affiliate of the Stanford Center on Longevity and Stanford Center for International Development. His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, and hepatitis C and on risk factors including smoking, physical activity, obesity, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues. Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011.

Contact

See biography

Publications

Chin, E., Leidner, D., Zhang, Y., Long, E., Prince, L., Schrag, S., Verani, J., Wiegand, R., Alarid-Escudero, F., Goldhaber-Fiebert, J., Studdert, D., Andrews, J., & Salomon, J. (2022). Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: Retrospective cohort study. Clinical Infectious Diseases, 75(1), e838-e845. https://doi.org/10.1093/cid/ciab1032
Chin, E., Ryckman, T., Prince, L., Leidner, D., Alarid-Escudero, F., Andrews, J., Salomon, J., Studdert, D., & Goldhaber-Fiebert , J. (2021). COVID-19 in the California state prison system: An observational study of decarceration, ongoing risks, and risk factors. Journal of General Internal Medicine, 36(10), 3096-3102. https://doi.org/10.1007/s11606-021-07022-x
Chin, E., Leidner, D., Ryckman, T., Liu, Y., Prince, L., Alarid-Escudero, F., Andrews, J., Salomon, J., Goldhaber-Fiebert, J., & Studdert, D. (2021). COVID-19 vaccine acceptance in California state prisons. New England Journal of Medicine, 385(4), 374-376. https://doi.org/doi:10.1056/NEJMc2105282
Alarid-Escudero, F., Gracia, V., Luviano, A., Roa, J., Peralta, Y., Reitsma, M., Claypool, A., Salomon, J., Studdert, D., Andrews, J., Goldhaber-Fiebert, J., & SC-COSMO Modeling Consortium, . (2021). Dependence of COVID-19 policies on end-of-year holiday contacts in Mexico City metropolitan area: A modeling study. MDM Policy & Practice, 6(2), 23814683211049249. https://doi.org/10.1177/23814683211049249
Chin, E., Leidner, D., Long, E., Prince, L., Li, Y., Andrews, J., Studdert, D., Goldhaber-Fiebert, J., & Salomon, J. (2021). Effectiveness of the mRNA-1273 vaccine during a SARS-CoV-2 Delta outbreak in a prison. New England Journal of Medicine, 385(24), 2300-2301. https://doi.org/10.1056/NEJMc2114089
Reitsma, M., Salomon, J., & Goldhaber-Fiebert, J. (2021). Mapping inequality in SARS-CoV-2 household exposure and transmission risk in the USA. Journal of General Internal Medicine, 36(5), 1476-1478. https://doi.org/10.1007/s11606-021-06603-0
Ryckman, T., Chin, E., Prince, L., Leidner, D., Long, E., Studdert, D., Salomon, J., Alarid-Escudero, F., Andrews, J., & Goldhaber-Fiebert, J. (2021). Outbreaks of COVID-19 variants in US prisons: A mathematical modelling analysis of vaccination and reopening policies. Lancet Public Health, 6(10), e760-e770. https://doi.org/10.1016/S2468-2667(21)00162-6
Reitsma, M., Goldhaber-Fiebert, J., & Salomon, J. (2021). Quantifying and benchmarking disparities in COVID-19 vaccination rates by race and ethnicity. JAMA Network Open, 4(10), e2130343. https://doi.org/10.1001/jamanetworkopen.2021.30343
Reitsma, M., Claypool, A., Vargo, J., Shete, P., McCorvie, R., Wheeler, W., Rocha, D., Myers, J., Murray, E., Bregman, B., Dominguez, D., Nguyen, A., Porse, C., Fritz, C., Jain, S., Watt, J., Salomon, J., & Goldhaber-Fiebert, J. (2021). Racial/ethnic disparities in COVID-19 exposure risk, testing, and cases at the subcounty level in California. Health Affairs, 40(6), 870-878. https://doi.org/10.1377/hlthaff.2021.00098
Fung, H., Martinez, L., Alarid-Escudero, F., Salomon, J., Studdert, D., Andrews, J., Goldhaber-Fiebert, J., & SC-COSMO Modeling Group, . (2021). The household secondary attack rate of SARS-CoV-2: A rapid review. Clinical Infectious Diseases, 73(2), S138-S145. https://doi.org/10.1093/cid/ciaa1558